Autoimmune And Rheumatic Diseases
Patient with lupus treated with KYV-101 CAR T-cell therapy relapses after 5 months
A patient with lupus nephritis treated with KYV-101, a chimeric antigen receptor T-cell immunotherapy, saw their disease return 5 months after initially showing a response to the treatment, according to the manufacturer.
New EULAR trial network to clear research pathways ‘fraught with banana skins’
The goal of a new EULAR initiative linking trial centers across Europe is quicker, more efficient clinical trials across the spectrum of rheumatic diseases, according to a speaker at the EULAR 2024 Congress.
Transition from pediatric to adult rheumatic care plagued by ‘lack of clear information’
Caregivers of pediatric rheumatology patients transitioning to adult care reported a “lack of clear information” on the necessary procedures, according to data presented at the EULAR 2024 Congress.
New EULAR trial center network, databases ‘crucial’ to advancing RMD care quality
A new trial center network and two major data collection projects are among recent EULAR initiatives for improved care of patients with rheumatic and musculoskeletal diseases, according to a speaker at the EULAR 2024 Congress.
Uplizna reduces IgG4 related disease flare risk by 87% in MITIGATE trial
The monoclonal antibody Uplizna met key endpoints in a phase 3 trial for the treatment of IgG4-related disease, marking the first time a placebo-controlled study has shown benefit in the condition, according to a press release from Amgen.
Third COVID-19 vaccine dose beneficial for most immunocompromised patients
A third dose of COVID-19 vaccine can boost serological and T-cell response among most patients who are immunocompromised, according to data published in The Lancet Rheumatology.
ACR launches free website with rheumatology guidance for primary care physicians
The American College of Rheumatology has launched a free online resource to help primary care physicians identify and treat rheumatic conditions.
Emotions and pain: The role of empathy
For readers of my column over the past decade, many will recognize that on numerous occasions I have chosen to discuss empathy.
Rheumatology clinic boosts smoking cessation referrals 20-fold with Quit Connect program
A rheumatology clinic initiative to connect patients with smoking cessation resources was feasible, cost-effective and boosted referrals to the state quit line 20-fold, according to data published in Arthritis Care & Research.
Changes in infusion drug insurance coverage jeopardize ‘hard-won’ disease control
An increasing number of insurance carriers are cutting out infusion centers and small practices for the delivery of infusion medications, and the impact on patient care could be profound.